Speed of Lung Inflation During Ventilation of Extremely Preterm Infants

NCT ID: NCT07101419

Last Updated: 2025-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-28

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Babies born extremely preterm (\<28 weeks of pregnancy) require support to breathe. Some babies require help to breathe from a breathing machine (mechanical ventilator). While this keeps babies alive, it may damage their lungs. To reduce this damage, doctors and nurses take particular care to try and provide the gentlest breathing support possible. However, evidence is still required to determine how to best support babies' breathing, whilst preventing lung damage and longer-term lung problems.

This clinical trial aims to compare two ways of adjusting a common setting on the breathing machine. This setting is called the pressure rise time or PRT. The PRT determines how quickly the breathing machine inflates a premature baby's lungs. A short PRT quickly inflates the lungs. A long PRT inflates the lungs more slowly. Previous research suggests that more slowly inflating the baby's lungs may cause less lung damage and still allow oxygen to be delivered to and carbon dioxide to be cleared from the lungs. However, larger studies are required to determine whether this should become the standard treatment.

This study investigates whether inflating the baby's lungs more slowly (long PRT) using the breathing machine is as effective as the PRT setting currently used (short PRT, more quickly inflating the lungs).

The main question it aims to answer is: Does how quickly the breathing machine inflates an extremely preterm baby's lung impact their oxygen levels?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The FLOW-VENT trial will investigate if using a long pressure rise time (PRT; thereby reducing the speed of gas flow) compared to a short PRT, during synchronised, patient-triggered, volume-targeted conventional mechanical ventilation in extremely preterm infants within the first postnatal week impacts an infant's oxygenation.

All infants born extremely preterm (\<28 weeks' gestation) require breathing support to survive. However, this support can damage their lungs. Rates of bronchopulmonary dysplasia (BPD), the chronic lung disease of extreme prematurity, are increasing. This is despite 'lung protective' respiratory support and ventilation strategies that aim to minimise harm to the preterm lung.

Pre-clinical evidence suggests that gas flows lower than currently used during respiratory support of these infants may be a major, and easily modifiable way of reducing preterm lung injury (Tingay 2024; Bach 2012). Current guidelines lack evidence for suggested gas flow settings. Many ventilators now modulate ventilator gas flows by a setting known as pressure rise time (PRT).

FLOW-VENT is a prospective, multicentre, unblinded, randomised crossover trial enrolling 68 extremely preterm infants born \<28 weeks gestational age. A long PRT is defined as a PRT set at 75% of the inspiratory time (Ti). A short PRT is defined as a PRT set at 33% of the Ti.

Given the crossover design, infants will receive both the long and short PRT setting. Extremely preterm infants will be randomised to a 'sequence' which will determine the order in which they are exposed to the different PRTs; either:

* Long-Short PRT Sequence: Long PRT in the first treatment period and Short PRT in the second treatment period, OR
* Short-Long PRT Sequence: Short PRT in the first treatment period and Long PRT in the second treatment period.

The trial crossover phase (\~10-12 hours) consists of: 1) Preparatory washout period (1 to 2 hours); 2) First treatment period (4-hours); 3) Washout period (1 to 2 hours); 4) Second treatment period (4-hours). Following this, there is a 12-hour follow-up period to monitor for adverse/safety events. The primary outcome (average S/F ratio) is assessed only during the 4-hour treatment periods.

Results from this trial will inform the decision to proceed to a larger randomised trial, powered for longer term respiratory outcomes (e.g. time to extubation from mechanical ventilation, BPD at 36 weeks' postmenstrual age).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome in Premature Infant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Extremely preterm infants on synchronised, patient-triggered, volume targeted conventional mechanical ventilation are managed with each pressure rise time (PRT) setting for 4 hours (treatment period 1), prior to crossing over to the other PRT setting for a further 4 hours (treatment period 2). There will be a 1-2 hour preparatory washout phase prior to treatment period 1 and another 1-2 hour washout between treatment period 1 and 2. Infants will be monitored for a further 12-hours post-completion of the crossover trial for safety events.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Long-Short PRT Sequence

Long PRT set during first treatment period; Short PRT set during second treatment period

Group Type EXPERIMENTAL

Long PRT

Intervention Type OTHER

PRT (in seconds) set at 75% of inspiratory time (in seconds)

Short PRT

Intervention Type OTHER

PRT (in seconds) set at 33% of inspiratory time (in seconds).

Short-Long PRT Sequence

Short PRT set during first treatment period; Long PRT set during second treatment period

Group Type EXPERIMENTAL

Long PRT

Intervention Type OTHER

PRT (in seconds) set at 75% of inspiratory time (in seconds)

Short PRT

Intervention Type OTHER

PRT (in seconds) set at 33% of inspiratory time (in seconds).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Long PRT

PRT (in seconds) set at 75% of inspiratory time (in seconds)

Intervention Type OTHER

Short PRT

PRT (in seconds) set at 33% of inspiratory time (in seconds).

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Long Pressure Rise Time Short Pressure Rise Time

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to participating neonatal intensive care unit
* Born between 22+0 to 27+6 weeks' gestation
* Current weight ≥400 grams
* Receiving synchronised, patient-triggered, volume-targeted (all breaths) conventional mechanical ventilation (Pressure Control-Assist Control + Volume Guarantee \[PC-AC+VG\] mode on Dräger Babylog VN500/800 ventilators) initiated within 72-hours post birth
* Postnatal age ≥6 hours and ≤7 days
* Received surfactant therapy
* Clinically stable (as per treating and research team consensus)
* Parent(s)/legal guardian provides prospective informed consent.

Exclusion Criteria

* Major congenital anomaly involving the cardiac, respiratory or gastrointestinal systems, or a known genetic syndrome or diagnosis that might affect respiratory course and outcomes
* Severe pulmonary hypoplasia due to anhydramnios or oligohydramnios before 22 weeks in which the neonatal consultant anticipates that pulmonary hypoplasia related respiratory failure will be the major respiratory problem in early postnatal life
* Receiving (or expected to receive within the next 12 hours) any other mode of mechanical ventilation including synchronised intermittent mandatory ventilation (SIMV), pressure support ventilation (PSV) or high-frequency oscillatory ventilation
* Planned for extubation from mechanical ventilation within the next 12 hours.
Minimum Eligible Age

6 Hours

Maximum Eligible Age

7 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mercy Hospital for Women, Australia

OTHER

Sponsor Role collaborator

Royal Women's Hospital, Melbourne, Australia

UNKNOWN

Sponsor Role collaborator

Western Health, Australia

OTHER_GOV

Sponsor Role collaborator

Murdoch Childrens Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kristin N Ferguson, BSc MBBS

Role: PRINCIPAL_INVESTIGATOR

Murdoch Childrens Research Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mercy Hospital for Women

Heidelberg, Victoria, Australia

Site Status

The Royal Women's Hospital

Parkville, Victoria, Australia

Site Status

Joan Kirner Women's and Children's Hospital

Saint Albans, Victoria, Australia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kristin N Ferguson, BSc MBBS

Role: CONTACT

+61383416200

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Brett Manley, MBBS(Hons) FRACP PhD

Role: primary

61384584444

Kristin Ferguson, BSc MBBS

Role: backup

Kate Hodgson, BMSc MBBS(Hons) PhD

Role: primary

61383452000

Kristin Ferguson, BSc MBBS

Role: backup

Arun Sett, MBBS(Hons) FRACP PhD

Role: primary

61383451333

References

Explore related publications, articles, or registry entries linked to this study.

Tingay DG, Fatmous M, Kenna K, Chapman J, Douglas E, Sett A, Poh QH, Dahm SI, Quach TK, Sourial M, Fang H, Greening DW, Pereira-Fantini PM. Speed of lung inflation at birth influences the initiation of lung injury in preterm lambs. JCI Insight. 2024 Aug 6;9(18):e181228. doi: 10.1172/jci.insight.181228.

Reference Type BACKGROUND
PMID: 39106107 (View on PubMed)

Sherer JL. Survey highlights the occupational hazards of nursing. Hospitals. 1993 May 20;67(10):60. No abstract available.

Reference Type BACKGROUND
PMID: 8491472 (View on PubMed)

Bach KP, Kuschel CA, Oliver MH, Bloomfield FH. Ventilator gas flow rates affect inspiratory time and ventilator efficiency index in term lambs. Neonatology. 2009;96(4):259-64. doi: 10.1159/000220765. Epub 2009 May 27.

Reference Type BACKGROUND
PMID: 19478530 (View on PubMed)

Riley M. Testimony of the American Society for Microbiology before the House Subcommittee on Investigations and Oversight, House Subcommittee on Natural Resources, Agriculture Research and Environment, and the House Subcommittee on Science, Research and Technology of the House Committee on Science and Technology. Hearing on "The coordinated framework for the regulation of biotechnology", July 23, 1986. Recomb DNA Tech Bull. 1986 Sep;9(3):151-61. No abstract available.

Reference Type BACKGROUND
PMID: 3466239 (View on PubMed)

Chong D, Kayser S, Szakmar E, Morley CJ, Belteki G. Effect of pressure rise time on ventilator parameters and gas exchange during neonatal ventilation. Pediatr Pulmonol. 2020 May;55(5):1131-1138. doi: 10.1002/ppul.24724. Epub 2020 Mar 9.

Reference Type BACKGROUND
PMID: 32150670 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

117784

Identifier Type: -

Identifier Source: org_study_id